Researchers will be exploring whether a new, very low cost, one-a-day combined ‘polypill’ could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial. The new ‘Red Heart Pill’ contains low-dose aspirin, a statin and two blood pressure-lowering medicines in a single polypill.